Commentary
Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other Assessments Based on the Simplified Negative and Positive Symptoms Interview (SNAPSI)
by Søren D. Østergaard, MD, PhD; Mark G. A. Opler, PhD, MPh; and Christoph U. Correll, MD Dr. Østergaard is Associate Professor at Aarhus University in Denmark. Dr. Opler is Adjunct Assistant Professor at NYU School of Medicine and Chief Research Officer at MedAvante-ProPhase, Inc. Dr. Correll is Medical Director of the Recognition and Prevention program […]
When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents
by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest relevant to the content of this article. Keywords: Opioids, diversion, safety, confidentiality, adolescents Abstract: Patients receiving […]
It’s Time for Combination Therapies in Multiple Sclerosis
by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South Carolina. Innov Clin Neurosci. 2017;14(5–6):28–30. Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest […]
Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms
by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40. Funding: No funding was received for the preparation of this article. Financial disclosures: The author has no conflicts of interest relevant to the content of […]
The Right to Die in Chronic Disorders of Consciousness: Can We Avoid the Slippery Slope Argument?
by Rocco Salvatore Calabrò, MD, PhD; Antonino Naro, MD, PhD; Rosaria De Luca, MS, PhD; Margherita Russo, MD, PhD; Lory Caccamo, PhD; Alfredo Manuli, MS; Alessia Bramanti; and Placido Bramanti, MD Drs. Calabró, Naro, de Luca, Russo, Manuli, A. Bramanti, and P. Bramanti are from the IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy; and Dr. […]
The Bereavement Exclusion and DSM-5: An Update and Commentary
by Ronald W. Pies MD Dr. Pies is Professor of Psychiatry at SUNY Upstate Medical University, Syracuse, New York, and Clinical Professor of Psychiatry at Tufts University School of Medicine in Boston. Innov Clin Neurosci. 2014;11(7–8):19–22
Are Antidepressants Effective in the Acute and Long-term Treatment of Depression? Sic et Non
by Ronald Pies, MD Dr. Pies is Professor of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, and Clinical Professor of Psychiatry, Tufts University School of Medicine, Boston, Massachussetts. Innov Clin Neurosci. 2012;9(5–6):31–40
The Despotic Habit of Gambling
by Assad Meymandi, MD, PhD, DLFAPA Dr. Meymandi is in private practice as a psychiatrist and neurologist and serves as an adjunct professor of psychiatry at the University of North Carolina at Chapel Hill. He is a noted physician, editor, and philanthropist who frequently speaks and writes on diverse topics that relate to his interests […]
It’s Only a Little Ice: A Personal View with Companion Commentary
by Stephen G. Thein, PhD Dr. Thein is Director/Principal Investigator of Pacific Research Network, Inc., in San Diego, California. With companion commentary by Atul R. Mahableshwarkar, MD Dr. Mahableshwarkar is Senior Medical Director at Takeda Global Research & Development Center, Inc. in Deerfield, Illinois. Innov Clin Neurosci. 2012;9(2):21–25
Neuroscience is the Next Oncology
by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts. Prominent and expensive failures in Alzheimer’s disease therapies have led to a […]
Continue Reading